AbbVie
Utility Patent Applications
Last updated:
List of all AbbVie patents 191 in total
| Status | Patent |
|---|---|
Application | Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY Filling date: 12 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF Filling date: 12 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: Methods for Treating HCV Filling date: 12 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: Macrocyclic MCL-1 Inhibitors and Methods of Use Filling date: 12 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: PROCESS FOR THE PREPARATION OF (S)-2-AMINO-NON-8-ENOIC ACID Filling date: 12 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: ANTI-EGFR ANTIBODY DRUG CONJUGATES (ADC) AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: TETRACYCLIC BROMODOMAIN INHIBITORS Filling date: 12 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE 1 (ENPP-1) INHIBITORS AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: ANTI-EGFR ANTIBODY DRUG CONJUGATE FORMULATIONS Filling date: 12 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: Solid Pharmaceutical Compositions for Treating HCV Filling date: 12 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES Filling date: 12 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USER Filling date: 12 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: METHODS OF ADMINISTERING ELAGOLIX Filling date: 12 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: CARBIDOPA PRODRUGS Filling date: 12 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Bromodomain Inhibitors Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: Solid Pharmaceutical Compositions for Treating HCV Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: Therapeutic DLL4 Binding Proteins Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: Antibody Drug Conjugates with Cell Permeable BCL-XL Inhibitors Filling date: 12 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE Filling date: 12 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Filling date: 12 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: Methods for Treating HCV Filling date: 12 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE Filling date: 12 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: ANTI-EGFR ANTIBODY DRUG CONJUGATES (ADC) AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: Container Cap and Method of Piercing a Seal Covering an Opening of a Container Filling date: 12 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Filling date: 12 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: METHODS OF TREATING HEAVY MENSTRUAL BLEEDING Filling date: 12 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: Pharmaceutical Formulations for Subcutaneous Administration Filling date: 12 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE Filling date: 12 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: TREATMENT OF NON-SMALL CELL LUNG CANCER Filling date: 12 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: METHODS OF ADMINISTERING ELAGOLIX Filling date: 12 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES Filling date: 12 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: DIFLUOROALKYLCYCLOPROPYL AMINO ACIDS AND ESTERS, AND SYNTHESES THEREOF Filling date: 12 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: SYNTHETIC ROUTE TO ANTI-VIRAL AGENTS Filling date: 12 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Showing 100 to 150 of 191 patents.